SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: DaiS who wrote (11179)7/10/1998 7:55:00 PM
From: DaiS  Read Replies (1) | Respond to of 23519
 
OK I had a go. Ratios USA/UK

Population: 280/60
Muse revenue 6.1/9.8
Revenue per unit x/y

Suppose x/y = 4/2 (twice as much revenue in USA: but tell me what reasonable x and y values are?)

Then relative sales effectiveness =

[(9.8/2)/60]/[(4/6.1)/280] = 15

Astra 1500% more effective than Vivus

FWIW Famous BigScane/LookNout4U said on Yahoo today that muse in top 11(?) best selling drugs ever in UK

DaiS